• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. BIOGLUE SYRINGE 5-PACK, 10ML; GLUE,SURGICAL,ARTERIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. BIOGLUE SYRINGE 5-PACK, 10ML; GLUE,SURGICAL,ARTERIES Back to Search Results
Model Number BG3510-5-J
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190); Appropriate Term/Code Not Available (3191)
Patient Problem Fever (1858)
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
Incidence of postoperative pyrexia of about 38 degrees has been observed after 2-3 weeks from the time of operation.It was considered to be infection-attributable in the beginning, but white blood cell count is stable and inflammation was within the normal range, the doctor now considers it might be bioglue-related.Bioglue was applied to false lumen, suture lines at aortic root as well as distal aortic arch.
 
Event Description
Incidence of postoperative pyrexia of about 38 degrees has been observed after 2-3 weeks from the time of operation.It was considered to be infection-attributable in the beginning, but white blood cell count is stable and inflammation was within the normal range, the doctor now considers it might be bioglue-related.Bioglue was applied to false lumen, suture lines at aortic root as well as distal aortic arch.
 
Manufacturer Narrative
Additional information received from the complainant does not attribute postoperative pyrexia to bioglue.Bioglue is a terminally sterilized product and it is highly unlikely it would contribute or be the cause of postoperative pyrexia.This event does not identify additional hazards or modify the probability and severity of existing hazards.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Additional information from the complainant indicates that the use of bioglue is not related to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOGLUE SYRINGE 5-PACK, 10ML
Type of Device
GLUE,SURGICAL,ARTERIES
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
MDR Report Key8640662
MDR Text Key146075160
Report Number1063481-2019-00031
Device Sequence Number1
Product Code MUQ
Combination Product (y/n)N
PMA/PMN Number
P010003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 07/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberBG3510-5-J
Device Lot Number18EJX001
Was Device Available for Evaluation? No
Distributor Facility Aware Date05/15/2019
Initial Date Manufacturer Received 05/15/2019
Initial Date FDA Received05/24/2019
Supplement Dates Manufacturer Received05/15/2019
Supplement Dates FDA Received07/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-